TotalSeq™-C0399 anti-human CD204 Antibody, 7C9C20,BioLegend,371911

Host

Mouse

Reactivity

Human

Application

PG - Quality tested

Platform ID

BAB733238665

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C0399 anti-human CD204 Antibody, 7C9C20
Cat. No.371911
HostMouse
RRIDAB_2888726 (BioLegend Cat. No. 371911)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationPG - Quality tested
ClonalityMonoclonal
Clone Number7C9C20
Concentration0.5 mg/mL
TargetCD204
ImmunogenRecombinant extracellular domain of human CD204.
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD204, also known as scavenger receptor A (SR-A) and the macrophage scavenger receptor (MSR), is one of the phagocytic pattern-recognition receptors (PRRs) expressed on macrophages and dendritic cells. CD204 was initially identified as a receptor mediating recognition and internalization of low-density lipoprotein (LDL) by macrophages and playing critical roles in atherogenesis. CD204 recognizes apoptotic cells, modified lipid proteins, and exogenous pathogen-associated molecular patterns (PAMPs), which results in the induction of innate immune and inflammatory responses. CD204 can act as a co-receptor for Toll-like receptors, such as TLR3, TLR4, or TLR9, to facilitate the expression of proinflammatory cytokines. CD204 has been implicated in several pathological processes such as Alzheimer’s disease, sepsis, ischemic injury, and coronary artery disease.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.